PSNL Merger Notice: BFA Law Notifies Personalis Shareholders of the Ongoing Investigation into the $16.25 per Share Merger

Bleichmar Fonti & Auld LLP says it is investigating the announced merger under which Tempus AI is set to acquire all outstanding Personalis shares for $16.25 per share, taking Personalis private. The announcement invites current Personalis stockholders to contact the firm; it provides no further details about the investigation or any alleged harm.

Analysis

The investigation announcement is not evidence of deal misconduct or a filed challenge; absent a complaint, court action, or proxy disclosures identifying a substantive defect, it should add little to the probability-weighted deal calculus. The direct market mechanism is therefore still merger-arbitrage math: PSNL’s upside is capped near $16.25 per share, while its downside on a failed transaction is uncapped relative to that consideration. The relevant near-term variable is the spread to the offer, not the law firm’s announcement. For TEM, the financial exposure depends on consideration form, financing, termination terms, and the target’s contribution to the combined business—none of which are established here. The stated commercial-associate relationship is a diligence flag, not proof of a conflict or a reason by itself to expect a deal revision. Over the next 1–3 months, monitor definitive proxy materials, any formal litigation or regulatory challenge, shareholder approval, and closing conditions. The contrarian read is that this is likely routine deal-investigation outreach with limited incremental information; overreacting to it could create a PSNL spread opportunity, but only if the spread compensates for break risk. No defensible valuation-based break price or TEM hedge ratio can be set from the supplied facts.

Key Decisions for Investors

• Do not treat the investigation headline alone as a reason to short PSNL or revise deal odds. Verify whether an actual complaint is filed and whether it seeks to delay or enjoin the merger.
• Watch PSNL’s price relative to $16.25 and calculate the implied annualized spread only after confirming consideration form, expected close date, shareholder and regulatory approvals, financing, and termination rights.
• Consider a PSNL merger-arbitrage position only if the spread adequately compensates for a documented break scenario; size against the potential gap to standalone value, which is not provided here. Avoid an unsupported fixed target or hedge ratio.
• For TEM, monitor proxy disclosures and deal terms for funding, dilution, and any material change in economics. Reassess if formal litigation, a closing-condition issue, or a substantive price/terms revision emerges.